Use of isavuconazole in mucormycosis: a systematic review

Use of isavuconazole in mucormycosis: a systematic review

Abstract Background Mucormycosis is an opportunistic fungal infection which is associated with poor prognosis. Only a few antifungals are available in the arsenal against mucormycosis. The global guidelines for diagnosing and managing mucormycosis recommend high doses of liposomal amphotericin B (LA...

Full description

Saved in:
Bibliographic Details
Main Authors: Shobha Sanjeewani Gunathilaka, Reshani Kaumada Keragala, Kasun Madhumal Gunathilaka, Sujanthi Wickramage, Sachithra Ravindi Bandara, Indika Sanjeewa Senevirathne, Asela Sampath Jayaweera
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Infectious Diseases
Subjects:
Antifungals
Isavuconazole
Mucormycosis
Online Access:https://doi.org/10.1186/s12879-025-10439-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12879-025-10439-y

Similar Items